Literature DB >> 15513927

Conformational flexibility in crystal structures of human 11beta-hydroxysteroid dehydrogenase type I provide insights into glucocorticoid interconversion and enzyme regulation.

David J Hosfield1, Yiqin Wu, Robert J Skene, Mark Hilgers, Andy Jennings, Gyorgy P Snell, Kathleen Aertgeerts.   

Abstract

Human 11beta-hydroxysteroid dehydrogenase type I (11beta-HSD1) is an ER-localized membrane protein that catalyzes the interconversion of cortisone and cortisol. In adipose tissue, excessive cortisol production through 11beta-HSD1 activity has been implicated in the pathogenesis of type II diabetes and obesity. We report here biophysical, kinetic, mutagenesis, and structural data on two ternary complexes of 11beta-HSD1. The combined results reveal flexible active site interactions relevant to glucocorticoid recognition and demonstrate how four 11beta-HSD1 C termini converge to form an as yet uncharacterized tetramerization motif. A C-terminal Pro-Cys motif is localized at the center of the tetramer and forms reversible enzyme disulfides that alter enzyme activity. Conformational flexibility at the tetramerization interface is coupled to structural changes at the enzyme active site suggesting how the central Pro-Cys motif may regulate enzyme activity. Together, the crystallographic and biophysical data provide a structural framework for understanding 11beta-HSD1 activities and will ultimately facilitate the development of specific inhibitors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15513927     DOI: 10.1074/jbc.M411104200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  On-column ligand exchange for structure-based drug design: a case study with human 11β-hydroxysteroid dehydrogenase type 1.

Authors:  Wenying Qin; Russell A Judge; Kenton L Longenecker; Larry R Solomon; John E Harlan
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-04-21

2.  Mutations of key hydrophobic surface residues of 11 beta-hydroxysteroid dehydrogenase type 1 increase solubility and monodispersity in a bacterial expression system.

Authors:  Alexander J Lawson; Elizabeth A Walker; Scott A White; Timothy R Dafforn; Paul M Stewart; Jonathan P Ride
Journal:  Protein Sci       Date:  2009-07       Impact factor: 6.725

3.  Biochemical studies and ligand-bound structures of biphenyl dehydrogenase from Pandoraea pnomenusa strain B-356 reveal a basis for broad specificity of the enzyme.

Authors:  Sonali Dhindwal; Dipak N Patil; Mahmood Mohammadi; Michel Sylvestre; Shailly Tomar; Pravindra Kumar
Journal:  J Biol Chem       Date:  2011-08-31       Impact factor: 5.157

Review 4.  Crystal structures of 11β-hydroxysteroid dehydrogenase type 1 and their use in drug discovery.

Authors:  Mark P Thomas; Barry V L Potter
Journal:  Future Med Chem       Date:  2011-03       Impact factor: 3.808

5.  Molecular docking and structural analysis of cofactor-protein interaction between NAD⁺ and 11β-hydroxysteroid dehydrogenase type 2.

Authors:  Hideaki Yamaguchi; Tatsuo Akitaya; Tao Yu; Yumi Kidachi; Katsuyoshi Kamiie; Toshiro Noshita; Hironori Umetsu; Kazuo Ryoyama
Journal:  J Mol Model       Date:  2011-06-11       Impact factor: 1.810

Review 6.  Virtual screening applications in short-chain dehydrogenase/reductase research.

Authors:  Katharina R Beck; Teresa Kaserer; Daniela Schuster; Alex Odermatt
Journal:  J Steroid Biochem Mol Biol       Date:  2017-03-09       Impact factor: 4.292

7.  Comparison of a homology model and the crystallographic structure of human 11beta-hydroxysteroid dehydrogenase type 1 (11betaHSD1) in a structure-based identification of inhibitors.

Authors:  Laurence Miguet; Ziding Zhang; Maryse Barbier; Martin G Grigorov
Journal:  J Comput Aided Mol Des       Date:  2006-04-20       Impact factor: 3.686

8.  Sequence and expression of 11beta-hydroxysteroid dehydrogenase type 1 cDNA cloned from pig testis.

Authors:  Shuji Ohno; Masanori Ohta; Yoko Honda; Shizuo Nakajin
Journal:  Mol Cell Biochem       Date:  2009-12-18       Impact factor: 3.396

Review 9.  Therapeutic manipulation of glucocorticoid metabolism in cardiovascular disease.

Authors:  Patrick W F Hadoke; Javaid Iqbal; Brian R Walker
Journal:  Br J Pharmacol       Date:  2009-02-23       Impact factor: 8.739

10.  Depot-specific regulation of the conversion of cortisone to cortisol in human adipose tissue.

Authors:  Mi-Jeong Lee; Susan K Fried; Steven S Mundt; Yanxin Wang; Sean Sullivan; Alice Stefanni; Bruce L Daugherty; Anne Hermanowski-Vosatka
Journal:  Obesity (Silver Spring)       Date:  2008-04-03       Impact factor: 5.002

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.